RayThera, Inc. Secures $110M in Series A Funding for Immunology Therapies

RayThera, Inc. successfully concludes its Series A financing, raising $110 million to advance immunology therapies.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here